申请人:Berger Jacob
公开号:US20050124613A1
公开(公告)日:2005-06-09
Compounds of the formula (I):
or pharmaceutically acceptable salts, solvates or prodrugs thereof, where R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
, R
9
, X, Y and m are as defined herein. Also provided are compositions comprising, methods for using, and methods for preparing compound of formula (I).
化合物的公式(I):或其药学上可接受的盐、溶剂合物或前药,其中R1、R2、R3、R4、R5、R6、R7、R8、R9、X、Y和m的定义如本文所述。还提供了包含该化合物的组合物、使用该化合物的方法以及制备该化合物的方法。